跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
NMPA
/
Recombinant Coagulation Factor VIII for Injection
Approved
生物制品
Recombinant Coagulation Factor VIII for Injection
GC Biopharma Corp.
🇨🇳 National Medical Products Administration
Approval Date
Aug 5, 2021
Approval ID
8CYmIORYf2h
Company
GC Biopharma Corp.
Type
生物制品
Approval Details
Approval Id
8CYmIORYf2h
Approval Number
国药准字SJ20210021
Generic Name
注射用重组人凝血因子Ⅷ
Generic Name En
Recombinant Coagulation Factor VIII for Injection
Trade Name
绿茵芷
Drug Type
生物制品
Dosage Form
注射剂
Strength
500IU/瓶
Reg Date
2021-08-05
Expired Date
2026-08-04
Company Name
GC Biopharma Corp.
Production Company Name
GC Biopharma Corp.
Company Detail Path
/organization/gc-biopharma-corp
Production Company Detail Path
/organization/gc-biopharma-corp
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Aug 5, 2021
Approval ID
8CYmIORYf2h
Type
生物制品
Back to NMPA Approvals
绿茵芷 - NMPA Drug Approval Details
